Teva Pharmaceutical Industries Limited (TEVA)
NYSE: TEVA · Real-Time Price · USD
18.07
+0.47 (2.67%)
At close: May 8, 2025, 4:00 PM
18.09
+0.02 (0.11%)
After-hours: May 8, 2025, 4:44 PM EDT

Teva Pharmaceutical Market Cap

Teva Pharmaceutical has a market cap or net worth of $20.73 billion as of May 8, 2025. Its market cap has increased by 43.53% in one year.

Market Cap
20.73B
Enterprise Value
35.97B
1-Year Change
43.53%
Ranking
Category
Stock Price
$18.07

Market Cap Chart

Since December 1, 1998, Teva Pharmaceutical's market cap has increased from $6.10B to $20.73B, an increase of 239.66%. That is a compound annual growth rate of 4.73%.

History

DateMarket Cap% Change
May 7, 202520.19B-19.16%
Dec 31, 202424.97B113.39%
Dec 29, 202311.70B15.54%
Dec 30, 202210.13B14.65%
Dec 31, 20218.84B-16.46%
Dec 31, 202010.58B-1.18%
Dec 31, 201910.70B-31.87%
Dec 31, 201815.71B-18.33%
Dec 29, 201719.23B-41.54%
Dec 30, 201632.90B-41.16%
Dec 31, 201555.92B2.69%
Dec 31, 201454.45B43.98%
Dec 31, 201337.82B7.52%
Dec 31, 201235.17B-7.04%
Dec 30, 201137.84B-21.40%
Dec 31, 201048.14B-3.59%
Dec 31, 200949.93B45.08%
Dec 31, 200834.41B-6.66%
Dec 31, 200736.87B83.46%
Dec 29, 200620.10B-25.46%
Dec 30, 200526.96B62.59%
Dec 31, 200416.58B13.05%
Dec 31, 200314.67B46.88%
Dec 31, 20029.99B-51.34%
Dec 29, 200020.52B104.36%
View and export this data all the way back to 1998. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Eli Lilly and Company 681.38B
Johnson & Johnson 375.20B
UnitedHealth Group 352.39B
AbbVie 328.50B
Novo Nordisk 287.72B
Abbott Laboratories 234.11B
Novartis AG 215.89B
AstraZeneca 208.98B
Market Cap Rankings